Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BioNTech News

Sophia Claire 2025 Aug 13, 00:00

Stifel Warns of Market Correction Amid Tariff Concerns and Economic Slowdown

Ava Grace 2025 Aug 13, 00:00

Inflation Risks Cloud Fed Rate Cut Bets

Ghko B 2025 Aug 11, 16:00

NBIS Stock Is Trending: How to Trade NBIS Stock CFD?

stocks
Ghko B 2025 Aug 11, 16:00

BTC Price Today: BTC/USD Jumped as Trump Extends China Tariffs Pause

crypto
Ghko B 2025 Aug 11, 16:00

CoreWeave Stock Analysis: What is the price target for CRWV?

stocks
Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Liam James 2025 Aug 13, 00:00

RBA Cuts Interest Rates: Analyzing the Implications and Market Expectations

Noah Lee 2025 Aug 13, 00:00

Fed's Response to Labor Market Data Concerns: Navigating Uncertainty

Liam James 2025 Aug 13, 00:00

US CPI July: Does Inflation Data Bolster Fed Rate Cut Expectations?

Noah Lee 2025 Aug 13, 00:00

Berkshire Hathaway's Secret Stock: Is It a $5 Billion Industrial Play?

Ava Grace 2025 Aug 13, 00:00

US Inflation Outlook: Tariffs, Fed Policy, and Gold Price Dynamics

Ava Grace 2025 Aug 13, 00:00

Trump Criticizes Powell, Calls for Rate Cuts Amid Inflation Concerns

Ava Grace 2025 Aug 13, 00:00

US CPI July 2024 Analysis: A Detailed Breakdown

Ava Grace 2025 Aug 12, 03:20

US CPI Data July: A Risky Economic Outlook Unveiled

Info

Spread

0.9653

Spread (%)

0.8744 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

26265995264

Shares Outstanding

240399008

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.66

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Aug 11, 16:00

Crypto CFD Trading: Bitcoin CFD, Solana CFD, MAGACOIN CFD

CFD Trading Crypto
Frances Wang 2025 Aug 11, 16:00

SoFi Stock Jumped: How to Trade SoFi Stock CFD online?

Stocks CFD Trading
Frances Wang 2025 Aug 11, 16:00

Trending Stock CFDs: CRWV Stock CFDs, NBIS Stock CFDs, TEM Stock CFDs

Stocks CFD Trading
Trustpilot